Nfa34810 Facilitates Invasion of Host Cells and Stimulates Tumor Necrosis Factor Alpha Secretion Through Activation of the NF-κB and Mitogen-Activated Protein Kinase Pathways Via Toll-Like Receptor 4
Overview
Authors
Affiliations
The mechanism underlying the pathogenesis of is not fully known. The Nfa34810 protein of has been predicted to be a virulence factor. However, relatively little is known regarding the interaction of Nfa34810 with host cells, specifically invasion and innate immune activation. In this study, we aimed to determine the role of recombinant Nfa34810 during infection. We demonstrated that Nfa34810 is an immunodominant protein located in the cell wall. Nfa34810 protein was able to facilitate the uptake and internalization of latex beads coated with Nfa34810 protein into HeLa cells. Furthermore, the deletion of the gene in attenuated the ability of the bacteria to infect both HeLa and A549 cells. Moreover, stimulation with Nfa34810 triggered macrophages to produce tumor necrosis factor alpha (TNF-α), and it also activated mitogen-activated protein kinase (MAPK) and nuclear factor κB (NF-κB) signaling pathways by inducing the phosphorylation of ERK1/2, p38, JNK, p65, and AKT in macrophages. Specific inhibitors of ERK1/2, JNK, and NF-κB significantly reduced the expression of TNF-α, which demonstrated that Nfa34810-mediated TNF-α production was dependent upon the activation of these kinases. We further found that neutralizing antibodies against Toll-like receptor 4 (TLR4) significantly inhibited TNF-α secretion. Taken together, our results indicated that Nfa34810 is a virulence factor of and plays an important role during infection. Nfa34810-induced production of TNF-α in macrophages also involves ERK, JNK, and NF-κB via the TLR4 pathway.
Secreted protein NFA47630 from Nocardia farcinica IFM10152 induces immunoprotective effects in mice.
Han L, Ji X, Fan S, Shen J, Liang B, Li Z Trop Dis Travel Med Vaccines. 2024; 10(1):21.
PMID: 39402651 PMC: 11476605. DOI: 10.1186/s40794-024-00229-w.
Shen J, Ji X, Han L, Yao J, Liang Y, Yuan M mSystems. 2024; 9(10):e0089324.
PMID: 39240104 PMC: 11494946. DOI: 10.1128/msystems.00893-24.
Chen S, Liu J, Huang S Front Pharmacol. 2024; 15:1370663.
PMID: 38953110 PMC: 11215192. DOI: 10.3389/fphar.2024.1370663.
Nathar S, Rajmichael R, Pandian C, Nagarajan H, Mathimaran A, Kingsley J Arch Microbiol. 2024; 206(2):76.
PMID: 38267747 DOI: 10.1007/s00203-023-03799-z.
Han L, Ji X, Yang C, Zhao S, Fan S, Zhao L Pathogens. 2022; 11(12).
PMID: 36558822 PMC: 9782307. DOI: 10.3390/pathogens11121488.